Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare systemic mastocytosis characterized by the presence of at least 20% usually immature and atypical mast cells in bone marrow aspirate smears. In classic mast cell leukemia, mast cells account for at least 10% of peripheral white blood cells, although the aleukemic variant with less than 10% mast cells is more common. C-findings (cytopenias, hepatomegaly, ascites, portal hypertension, splenomegaly, skeletal lesions, malabsorption), indicative of organ damage due to mast cell infiltration, are usually present at diagnosis, while skin lesions are absent in most cases. Prognosis is generally poor.
Biomarker and diagnostic research for acute mast cell leukemia has been reported in the published literature.
No clinical trials have been registered for acute mast cell leukemia.
15 publications have been identified in PubMed for acute mast cell leukemia. Research spans Case Report / Case Series (33%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:01 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acute mast cell leukemia
3 |
20% |
Laboratory research | 3 | 20% |
Clinical study results | 2 | 13% |
Other research | 1 | 7% |
Testing and diagnosis research | 1 | 7% |
Chamundaiah JP (2026). [PMID: 41755975](https://pubmed.ncbi.nlm.nih.gov/41755975/). *Cureus*. [Clinical Trial Publication]
Liu Y (2026). [PMID: 42180116](https://pubmed.ncbi.nlm.nih.gov/42180116/). *Front Oncol*. [Case Report / Case Series]
Wang L (2026). [PMID: 42087696](https://pubmed.ncbi.nlm.nih.gov/42087696/). *Cytometry B Clin Cytom*. [Other]
Li S (2025). [PMID: 39415365](https://pubmed.ncbi.nlm.nih.gov/39415365/). *International journal of laboratory hematology*. [Case Report / Case Series]
Unknown (2025). [PMID: 39454043](https://pubmed.ncbi.nlm.nih.gov/39454043/). *American journal of clinical pathology*. [Diagnostic / Biomarker]
Chin HS (2025). [PMID: 40121237](https://pubmed.ncbi.nlm.nih.gov/40121237/). *Nature communications*. [Review / Meta-Analysis]
Hunter DJ (2025). [PMID: 40278544](https://pubmed.ncbi.nlm.nih.gov/40278544/). *Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine*. [Review / Meta-Analysis]
Idamakanti M (2025). [PMID: 39935699](https://pubmed.ncbi.nlm.nih.gov/39935699/). *Journal of hematology*. [Basic Science / Preclinical]
Pan Z (2025). [PMID: 40673268](https://pubmed.ncbi.nlm.nih.gov/40673268/). *Leukemia research reports*. [Case Report / Case Series]
Xu J (2025). [PMID: 39244687](https://pubmed.ncbi.nlm.nih.gov/39244687/). *American journal of clinical pathology*. [Basic Science / Preclinical]